Ozempic In India
-
{
- All
- News
- Videos
- Web Stories
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
- Monday April 6, 2026
- Health | Written by Debosmita Ghosh
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
www.ndtv.com
-
Weight-Loss Drug Misuse Under Scanner, Centre Warns Of Legal Action For Violations
- Wednesday April 1, 2026
- Health | Reported by Tanushka Dutta
The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but are increasingly being accessed without proper prescriptions through retail and digital channels.
-
www.ndtv.com
-
Semaglutide Weight-Loss Drugs May Help Prevent Deadly Heart Attack Complications
- Monday March 30, 2026
- Written by Shreya Goswami
Popular weight-loss drugs like semaglutide may reduce life-threatening complications after heart attacks, a UK study finds. By improving blood flow in tiny vessels, these drugs could help the heart recover, but human trials are still needed.
-
doctor.ndtv.com
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
- Monday March 30, 2026
- Health | Written by Sambhav Kumar
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
www.ndtv.com
-
Affordable Weight Loss Drugs In India: How Cheap GLP-1s Will Affect Obesity Treatment
- Wednesday March 25, 2026
- Health | Written by Varsha Vats
Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to approach this transition with caution.
-
www.ndtv.com
-
Indian Woman Shares Reality Of Losing 30 Kg With Ozempic: "Your Stomach Refuses To Cooperate"
- Tuesday March 24, 2026
- Feature | Edited by Ritu Singh
She emphasised that the treatment is not a "shortcut" for weight management, noting it is a serious medication.
-
www.ndtv.com
-
Safety Checks For New Generic Weight-Loss Drugs To Be Increased: Government
- Tuesday March 24, 2026
- Health | Indo-Asian News Service
New Delhi, March 24 (IANS) Amid serious concerns over recent introduction of multiple generic variants of GLP-1 based weight loss drugs in the Indian market, the government on Tuesday said it has intensified regulatory surveillance against the drug’s
-
www.ndtv.com
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
- Saturday March 21, 2026
- Health | Reported by Tanushka Dutta
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
www.ndtv.com
-
How A YouTuber Lost 10 Kg With Mounjaro And What It Did To His Emotions: 'Life Was Flat'
- Saturday March 21, 2026
- Lifestyle | Written by Krati Purwar
A YouTuber shared that while he lost 10 kg with Mounjaro, he also felt deprived of emotions. Irrespective of the situation, he remained neutral
-
www.ndtv.com/lifestyle
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
- Thursday March 19, 2026
- Health | Written by Sambhav Kumar
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
www.ndtv.com
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
- Monday April 6, 2026
- Health | Written by Debosmita Ghosh
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
www.ndtv.com
-
Weight-Loss Drug Misuse Under Scanner, Centre Warns Of Legal Action For Violations
- Wednesday April 1, 2026
- Health | Reported by Tanushka Dutta
The crackdown comes at a time when GLP-1 drugs, widely used for weight loss and diabetes, are seeing a surge in demand, but are increasingly being accessed without proper prescriptions through retail and digital channels.
-
www.ndtv.com
-
Semaglutide Weight-Loss Drugs May Help Prevent Deadly Heart Attack Complications
- Monday March 30, 2026
- Written by Shreya Goswami
Popular weight-loss drugs like semaglutide may reduce life-threatening complications after heart attacks, a UK study finds. By improving blood flow in tiny vessels, these drugs could help the heart recover, but human trials are still needed.
-
doctor.ndtv.com
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
- Monday March 30, 2026
- Health | Written by Sambhav Kumar
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
www.ndtv.com
-
Affordable Weight Loss Drugs In India: How Cheap GLP-1s Will Affect Obesity Treatment
- Wednesday March 25, 2026
- Health | Written by Varsha Vats
Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to approach this transition with caution.
-
www.ndtv.com
-
Indian Woman Shares Reality Of Losing 30 Kg With Ozempic: "Your Stomach Refuses To Cooperate"
- Tuesday March 24, 2026
- Feature | Edited by Ritu Singh
She emphasised that the treatment is not a "shortcut" for weight management, noting it is a serious medication.
-
www.ndtv.com
-
Safety Checks For New Generic Weight-Loss Drugs To Be Increased: Government
- Tuesday March 24, 2026
- Health | Indo-Asian News Service
New Delhi, March 24 (IANS) Amid serious concerns over recent introduction of multiple generic variants of GLP-1 based weight loss drugs in the Indian market, the government on Tuesday said it has intensified regulatory surveillance against the drug’s
-
www.ndtv.com
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
- Saturday March 21, 2026
- Health | Reported by Tanushka Dutta
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
www.ndtv.com
-
How A YouTuber Lost 10 Kg With Mounjaro And What It Did To His Emotions: 'Life Was Flat'
- Saturday March 21, 2026
- Lifestyle | Written by Krati Purwar
A YouTuber shared that while he lost 10 kg with Mounjaro, he also felt deprived of emotions. Irrespective of the situation, he remained neutral
-
www.ndtv.com/lifestyle
-
Affordable Semaglutide Is Coming: Should You Be Worried About Drug Safety, Health Risks And Side Effects?
- Thursday March 19, 2026
- Health | Written by Sambhav Kumar
India's healthcare landscape will change as semaglutide patents expire in 2026, allowing over 50 generic versions to enter the market and improve access for diabetes and obesity treatment.
-
www.ndtv.com